Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRWD
DateTimeSourceHeadlineSymbolCompany
06/12/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
27/11/202408:01Business WireIronwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/11/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/11/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
16/11/202408:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
16/11/202408:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/11/202407:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRWDIronwood Pharmaceuticals Inc
14/11/202408:01Business WireIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
13/11/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/11/202409:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202423:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202423:00Business WireIronwood Pharmaceuticals Reports Third Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/10/202422:00Business WireOnce-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024NASDAQ:IRWDIronwood Pharmaceuticals Inc
25/10/202407:00Business WireIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
24/10/202408:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
30/09/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
30/08/202406:01Business WireIronwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/08/202407:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/08/202407:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/08/202406:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/08/202406:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202421:00Business WireIronwood Pharmaceuticals Reports Second Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
26/07/202406:00Business WireIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
13/06/202406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/06/202406:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/06/202406:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/06/202403:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/06/202405:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
31/05/202406:01Business WireIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IRWD